After years of silence and severe Alzheimer’s symptoms, a woman in her 80s experienced a dramatic but temporary return of speech, memory, and mobility following treatment with psilocybin, a hallucinogenic compound from magic mushrooms.
- Woman with severe Alzheimer’s spoke and moved again after psilocybin treatment
- Effects included improved memory, mood, and motor control lasting weeks
- Case opens potential for future Alzheimer’s therapies using psychedelics
What happened
A Japanese-American woman in her 80s who had lived with Alzheimer’s for a decade, and had been unable to speak for five years, was given a five-gram dose of psilocybin mushrooms under physician supervision. The dose was from a potent strain called Enigma. After hours of deep sleep and fever, she emerged lucid and began speaking at length, recalling personal memories and engaging with those around her.
Following the dose, she exhibited significant improvements in cognitive and physical abilities beyond just speech. Her working memory returned, she smiled, maintained eye contact, controlled her bladder, dressed herself, and walked with greater ease. A smaller second dose led to additional signals of recovery, including humor and emotionally rich conversation. These changes lasted for days to weeks.
Why it feels good
Alzheimer’s disease relentlessly strips away a person’s identity and ability to connect with loved ones, which can be devastating for families. To witness moments of genuine lucidity and personality after years of silence offers a deeply hopeful and emotional experience for caregivers and relatives alike.
While these remarkable effects were temporary, the case challenges long-held assumptions that parts of the Alzheimer’s brain are permanently lost. The glimpse of restored communication and function, even if brief, shines a light on new possibilities where psychedelic therapies might one day improve quality of life for those affected by neurodegenerative disorders.
What to enjoy or watch next
This case encourages further scientific study into psychedelic substances like psilocybin as potential treatments for Alzheimer’s and other cognitive diseases. Ongoing clinical trials are exploring how these therapies might safely unlock brain function and aid memory and emotional wellbeing.
For those interested in the evolving landscape of psychedelic medicine, many documentaries and research updates are available that examine the revival of psychedelics in mental health care, including their use for depression, anxiety, and neurodegeneration. Following reputable scientific outlets and health research news will provide the latest breakthroughs as this field expands.